{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Baltimore",
      "state": "MD",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "ANDA090034"
        ],
        "brand_name": [
          "RIFAMPIN"
        ],
        "generic_name": [
          "RIFAMPIN"
        ],
        "manufacturer_name": [
          "Lupin Pharmaceuticals, Inc."
        ],
        "product_ndc": [
          "68180-658",
          "68180-659"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "RIFAMPIN"
        ],
        "rxcui": [
          "198201",
          "198202"
        ],
        "spl_id": [
          "5ed1edac-e11e-4f87-b390-e770a69a9b37"
        ],
        "spl_set_id": [
          "b56004f0-f23d-47f6-80c7-39884fccbccc"
        ],
        "package_ndc": [
          "68180-658-06",
          "68180-658-01",
          "68180-659-06",
          "68180-659-07",
          "68180-659-01"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000175500",
          "M0019113"
        ],
        "pharm_class_epc": [
          "Rifamycin Antibacterial [EPC]"
        ],
        "pharm_class_cs": [
          "Rifamycins [CS]"
        ],
        "unii": [
          "VJT6J7R4TR"
        ]
      },
      "product_type": "Drugs",
      "event_id": "93753",
      "recalling_firm": "Lupin Pharmaceuticals Inc.",
      "address_1": "Harborplace Tower",
      "address_2": "111 S Calvert St Fl 21st",
      "postal_code": "21202-6174",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Product was distributed to 32 Wholesale/distributor accounts who further distributed the product to 156 distribution sites.",
      "recall_number": "D-0283-2024",
      "product_description": "Rifampin Capsules USP 150mg, 30-count bottle, Rx Only, Manufactured for:   Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States, Manufactured Lupin Limited, Aurangabad 431 210 INDIA, NDC 68180-658-06",
      "product_quantity": "15,576 Bottles",
      "reason_for_recall": "Subpotent Drug and Failed Impurities/Degradation Specifications",
      "recall_initiation_date": "20240105",
      "center_classification_date": "20240130",
      "termination_date": "20240827",
      "report_date": "20240207",
      "code_info": "A200816 exp 1/2024 A201248 exp 3/2024",
      "more_code_info": ""
    }
  ]
}